Rigel Pharmaceuticals

RIGLNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$879.635 M

$47.09 +0.96%

Close of 21 Sept 2026

Revenue

$294.3M

#2138 by revenue

Earnings

$367.0M

#753 by earnings

Shares outstanding

18,679,864

Latest filing cover page

P/E ratio

2.4

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#163Immix BiopharmaIMMX$892.1M
#164Theravance BiopharmaTBPH$885.2M
#165Rigel PharmaceuticalsRIGL$879.6M
#166ArdelyxARDX$872.2M
#167Avalo TherapeuticsAVTX$867.2M

What if Rigel Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$1,620,679

Per share 34,417× higher

Bitcoin $1.72T

$92,067.25

Per share 1,955× higher

Nvidia $5.48T

$293,356.42

Per share 6,230× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Rigel Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.